PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 8, 2026JAMA Internal Medicine2 citations

Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps

View Full Paper
DHDongzhe HongKCKrystal CantosDMDiana Morgenstern

Key Points

  • This research aims to evaluate the effect of a monthly insulin spending cap on access and health outcomes for Medicare beneficiaries with type 2 diabetes.
  • Conducted a cohort study focusing on Medicare beneficiaries with type 2 diabetes.
  • Implemented a $35 monthly cap on out-of-pocket spending for insulin.
  • Measured changes in insulin spending, access, and blood glucose levels.
  • Analyzed data before and after the cap was introduced.
  • Insulin out-of-pocket spending significantly decreased after the cap.
  • Access to insulin increased among beneficiaries.
  • Blood glucose levels decreased, indicating improved health outcomes.

Abstract

In this cohort study, a 35 monthly insulin out-of-pocket cap was found to be associated with significantly lower insulin out-of-pocket spending, increased access to insulin, and decreased blood glucose levels among Medicare beneficiaries with T2D. These findings suggest federal cost-sharing policies could improve access and adherence to essential medications in diabetes and other chronic diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hong et al. (2026) studied this question.

synapsesocial.com/papers/69d5f05d74eaea4b11a79c9ehttps://doi.org/10.1001/jamainternmed.2026.0255
Ask AI
Helpful
Bookmark
Share
View Full Paper